GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $258,000 | -9.8% | 6,200 | 0.0% | 0.12% | -13.5% |
| Q1 2015 | $286,000 | +7.9% | 6,200 | 0.0% | 0.13% | +4.7% |
| Q4 2014 | $265,000 | +3.1% | 6,200 | +10.7% | 0.13% | -1.6% |
| Q3 2014 | $257,000 | +6.6% | 5,600 | +24.4% | 0.13% | +13.2% |
| Q2 2014 | $241,000 | +0.4% | 4,500 | 0.0% | 0.11% | -7.3% |
| Q1 2014 | $240,000 | +12.1% | 4,500 | +12.5% | 0.12% | +8.8% |
| Q4 2013 | $214,000 | – | 4,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |